Insider buying
~$267K24K sh @ $10.98
Traded Dec 23, 2024 · filed 3 days later
A Benitec Biopharma director paid $267K out of pocket for Benitec Biopharma shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 3, 2024 · Filed Dec 5, 2024
A Benitec Biopharma director paid $357K out of pocket for Benitec Biopharma shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$357,024
Shares × reported transaction price
$100K–$500K
+0.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 4 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
19 days after results of Nov 14, 2024, 73 days before results of Feb 14, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.8% | −0.6% | +5.4% |
| 30 days | +2.3% | −2.0% | +4.4% |
| 90 days | +15.7% | −5.8% | +21.4% |
| 180 days | +37.9% | −1.9% | +39.8% |
| 365 days | +17.4% | +12.5% | +5.0% |
Past results only. Not a forecast.
Insider buying
Traded Dec 23, 2024 · filed 3 days later
A Benitec Biopharma director paid $267K out of pocket for Benitec Biopharma shares.
Insider buying
Traded Dec 23, 2024 · filed 3 days later
A Benitec Biopharma director paid $34K out of pocket for Benitec Biopharma shares.
Insider buying
Traded Dec 24, 2024 · filed 2 days later
A Benitec Biopharma director paid $199K out of pocket for Benitec Biopharma shares.
SUVRETTA CAPITAL MANAGEMENT, LLC, Director's past purchases, 90 days after disclosure: 5 buys, median +7.8 pts vs S&P 500, beat it 3 of 5 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.